Skip to main content
. Author manuscript; available in PMC: 2012 Jul 15.
Published in final edited form as: Bioorg Med Chem Lett. 2011 Jun 2;21(14):4164–4169. doi: 10.1016/j.bmcl.2011.05.098

Figure 1.

Figure 1

Pharmacophore model and representative structures of HDACi. Hydroxamic acid: suberoylanilide hydroxamic acid (SAHA) (1), benzamide: MS-275 (2), aliphatic acid: valproic acid (3), and cyclic peptides: largazole (4a) and trapoxin (4b).